You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 107 No. 7, July 1989 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  LABORATORY SCIENCES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Fibronectin Does Not Enhance Epidermal Growth Factor-Mediated Acceleration of Corneal Epithelial Wound Closure

H. Kaz Soong, MD; Tarek Hassan, MD; James Varani, PhD; Samuel C. M. Huang, MD; Mary Brennan, MS

Arch Ophthalmol. 1989;107(7):1052-1054.


Abstract



• Concomitant use of epidermal growth factor and fibronectin for the treatment of corneal epithelial wounds has a putative advantage of promoting complementary aspects of wound healing: epidermal growth factor enhances mitosis, while fibronectin increases cell-to-substrate adhesiveness and possibly cell motility. To determine if the combination of epidermal growth factor and fibronectin is synergistic in accelerating the speed of corneal epithelial wound coverage, epithelial wound closure rates were compared in serum-free rat corneal organ cultures among epidermal growth factor alone, fibronectin alone, their combination, and drug-free controls. Epidermal growth factor (50 to 1000 ng /mL) significantly increased the rate of wound closure over that of the drug-free controls, while fibronectin (50 to 100 µg mL) had no significant effect. Wound closure rates with combined epidermal growth factor and fibronectin were no faster than with epidermal growth factor alone. The results indicate that fibronectin does not accelerate the rate of corneal epithelial migration when used alone or in combination with epidermal growth factor. This may reflect that the major role of fibronectin may be in the enhancement of cell-to-substrate adhesion and not of migration per se.



Author Affiliations



From the Departments of Ophthalmology (Drs Soong, Hassan, and Huang and Ms Brennan) and Pathology (Dr Varani), University of Michigan Medical School, Ann Arbor.


Footnotes



Accepted for publication January 24, 1989.

Reprint requests to W. K. Kellogg Eye Center, 1000 Wall St, Ann Arbor, MI 48105 (Dr Soong).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Stimulation of Corneal Epithelial Migration by a Synthetic Peptide (PHSRN) Corresponding to the Second Cell-Binding Site of Fibronectin
Kimura et al.
IOVS 2007;48:1110-1118.
ABSTRACT | FULL TEXT  

Neolactoglycosphingolipids, Potential Mediators of Corneal Epithelial Cell Migration
Panjwani et al.
J. Biol. Chem. 1995;270:14015-14023.
ABSTRACT | FULL TEXT  

Topical Fibronectin in an Alkali Burn Model of Corneal Ulceration in Rabbits
Phan et al.
Arch Ophthalmol 1991;109:414-419.
ABSTRACT  

Topical Fibronectin and Aprotinin for Keratectomy Wound Healing in Rabbits
Boisjoly et al.
Arch Ophthalmol 1990;108:1758-1763.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.